| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 263.980 | 303.686 | 314.553 | 320.871 | 333.982 | 402.799 | 450.877 | 462.859 | 468.379 | 546.900 |
| Total Income - EUR | 263.998 | 304.168 | 314.650 | 320.879 | 333.997 | 402.807 | 451.344 | 466.383 | 468.601 | 561.525 |
| Total Expenses - EUR | 253.615 | 298.722 | 304.341 | 298.349 | 304.162 | 367.019 | 436.262 | 437.272 | 455.582 | 536.460 |
| Gross Profit/Loss - EUR | 10.384 | 5.446 | 10.309 | 22.531 | 29.835 | 35.788 | 15.082 | 29.111 | 13.020 | 25.064 |
| Net Profit/Loss - EUR | 8.597 | 4.233 | 7.356 | 19.322 | 26.495 | 32.047 | 10.875 | 24.863 | 9.072 | 19.276 |
| Employees | 6 | 5 | 6 | 8 | 4 | 5 | 5 | 6 | 6 | 6 |
Check the financial reports for the company - Tudor Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 20.613 | 19.857 | 19.093 | 48.847 | 73.607 | 57.943 | 66.952 | 52.934 | 74.709 |
| Current Assets | 101.965 | 81.842 | 75.405 | 80.776 | 94.134 | 107.095 | 78.994 | 105.335 | 151.753 | 156.920 |
| Inventories | 61.564 | 45.402 | 34.086 | 32.722 | 43.572 | 47.618 | 29.016 | 62.085 | 83.610 | 83.740 |
| Receivables | 20.736 | 12.673 | 36.478 | 37.477 | 36.384 | 48.666 | 47.678 | 42.072 | 45.586 | 38.988 |
| Cash | 19.665 | 23.768 | 4.842 | 10.577 | 14.178 | 10.811 | 2.300 | 1.178 | 22.558 | 13.794 |
| Shareholders Funds | 83.829 | 42.672 | 49.305 | 67.722 | 95.612 | 125.846 | 129.674 | 99.428 | 104.354 | 123.047 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 18.136 | 59.784 | 45.957 | 32.147 | 47.369 | 54.857 | 7.613 | 73.869 | 101.455 | 109.630 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Tudor Pharma Srl